Where are we and how far is there to go in the development of an Acinetobacter vaccine?-Reference-Cited by-同舟云学术

Where are we and how far is there to go in the development of an Acinetobacter vaccine?

Published:2021-02-20 Issue:3 Volume:20 Page:281-295
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Ma Crystal¹,Chen Wangxue¹²^ORCID

Affiliation:

1. Human Health Therapeutics Research Center (HHT), National Research Council Canada, Ottawa, Ontario Canada

2. Department of Biology, Brock University, St. Catharines, Ontario Canada

Funder

NRC-Ministry of Science and Technology

Vaccine and Emerging Infection Research Initiative, and NRC Ideation Small Team Project

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1887735

Reference139 articles.

1. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit

2. World Health Organization. http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/. 2017 (accessed 2020 Nov 20).

3. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. https://www.cdc.gov/drugresistance/biggest_threats.html. 2013:1–113 (accessed 2020 Nov 17).

4. Attitudes to vaccination: A critical review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Putative novel outer membrane antigens multi-epitope DNA vaccine candidates identified by Immunoinformatic approaches to control Acinetobacter baumannii;BMC Immunology;2023-11-18

2. Passive immunization with anti-FimA egg yolk antibodies (IgYs) mitigate Acinetobacter baumannii pneumonia in mice;Biomedicine & Pharmacotherapy;2023-11

3. Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis;Advanced NanoBiomed Research;2022-12-22

4. The K218 capsular polysaccharide produced by Acinetobacter baumannii isolate 52-249 includes 5,7-di-N-acetylpseudaminic acid linked by a KpsS3 glycosyltransferase;International Journal of Biological Macromolecules;2022-10

5. A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa;Scientific Reports;2022-06-27